METGBL
Various solid tumors (tyrosine kinase driven)
PreclinicalActive
Key Facts
Indication
Various solid tumors (tyrosine kinase driven)
Phase
Preclinical
Status
Active
Company
About Sathgen Therapeutics
Innovative plant‑derived oncology and antiviral drug developer with a Phase I lead candidate.
View full company profile